Skip to main content
Contact Us
Subscribe
E-Edition
86°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
stocks
Markets
Market Insider
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
US: News
Social issues
US Economy
From
CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
Health care industry
Business
Biogen Inc
From
CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
May 15, 2023
Tags
Mad Money
Investing
Eli Lilly and Co
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
US: News
Eli Lilly and Co
Health & Science
From
CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
May 03, 2023
Tags
Western Alliance Bancorp
Starbucks Corp
Business
From
CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
May 01, 2023
Tags
US Economy
US: News
U/S/ Economy
From
CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
April 30, 2023
Tags
US: News
US Economy
Quanterix Corp
From
CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
April 26, 2023
Tags
Health & Science
Policy
Disease outbreaks
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Pharmaceuticals
Health & Science
Eli Lilly and Co
From
CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags
Breaking news
Companies
Biogen Inc
From
CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags
Health care industry
Biogen Inc
Breaking news
From
CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
April 05, 2023
Tags
US: News
Eli Lilly and Co
Pharmaceuticals
From
CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
March 22, 2023
Tags
Health care industry
Health & Science
Pharmaceuticals
From
CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
Tags
Pharmaceuticals
Health & Science
US: News
From
CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
March 13, 2023
Tags
US Economy
US: News
U/S/ Economy
From
CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags
Business News
Eisai Co Ltd
Breaking News: Business
From
CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags
US Economy
US: News
US Top News and Analysis
From
CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
February 17, 2023
Tags
Zebra Technologies Corp
Stock markets
Albemarle Corp
From
CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
February 17, 2023
Tags
Breaking News: Business
Eisai Co Ltd
Business News
From
CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
February 17, 2023
Tags
World News
Biogen Inc
Business
From
CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
February 15, 2023
Tags
Market Insider
FactSet Research Systems Inc
Markets
From
CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
January 06, 2023
Tags
U/S/ Economy
Politics
US Top News and Analysis
From
CNBC.com News
Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more
December 23, 2022
Tags
3M Co
Market Insider
Markets
From
CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
December 23, 2022
Tags
Schlumberger NV
Stock markets
Twitter (delisted)
From
CNBC.com News
Stocks making the biggest moves midday: CrowdStrike, Horizon Therapeutics, Petco and more
November 30, 2022
Tags
Petco Health and Wellness Company Inc
Breaking News: Markets
Finance
From
CNBC.com News
Stocks making the biggest moves premarket: Hormel, Petco, CrowdStrike and more
November 30, 2022
Tags
Breaking News: Markets
Petco Health and Wellness Company Inc
Economy
From
CNBC.com News
Stocks making the biggest moves midday: Apple, DraftKings, Biogen, Williams-Sonoma and more
November 28, 2022
Tags
Breaking News: Markets
Economy
MGM Resorts International
From
CNBC.com News
Stocks making the biggest moves in the premarket: Apple, Taboola, Biogen and more
November 28, 2022
Tags
First Solar Inc
Investing
Wynn Resorts Ltd
From
CNBC.com News
Stocks making the biggest moves midday: Oatly, Amazon, Hasbro and more
November 14, 2022
Tags
Oatly Group AB
Business
Economy
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.